Ligand Pharmaceuticals (LGND) Receivables Refunds (2018 - 2025)
Historic Receivables Refunds for Ligand Pharmaceuticals (LGND) over the last 9 years, with Q3 2025 value amounting to $536000.0.
- Ligand Pharmaceuticals' Receivables Refunds fell 9313.96% to $536000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $536000.0, marking a year-over-year decrease of 9313.96%. This contributed to the annual value of $4.1 million for FY2024, which is 3630.96% down from last year.
- According to the latest figures from Q3 2025, Ligand Pharmaceuticals' Receivables Refunds is $536000.0, which was down 9313.96% from $828000.0 recorded in Q2 2025.
- Ligand Pharmaceuticals' Receivables Refunds' 5-year high stood at $7.8 million during Q3 2024, with a 5-year trough of $536000.0 in Q3 2025.
- Moreover, its 5-year median value for Receivables Refunds was $4.3 million (2025), whereas its average is $3.8 million.
- Its Receivables Refunds has fluctuated over the past 5 years, first surged by 17934.15% in 2021, then tumbled by 9313.96% in 2025.
- Over the past 5 years, Ligand Pharmaceuticals' Receivables Refunds (Quarter) stood at $6.2 million in 2021, then fell by 25.5% to $4.6 million in 2022, then soared by 38.6% to $6.4 million in 2023, then plummeted by 36.31% to $4.1 million in 2024, then crashed by 86.84% to $536000.0 in 2025.
- Its Receivables Refunds was $536000.0 in Q3 2025, compared to $828000.0 in Q2 2025 and $4.3 million in Q1 2025.